Curanail 5% Nail Lacquer Amorolfine - The Only Once Weekly Treatment for Mild Fungal Nail Infections

About Galderma

Galderma, a unique company in the pharmaceutical industry.

Since the creation of Galderma in 1981 as a joint venture between Nestlé and L'Oréal, all of our resources have been channelled in one direction: to provide innovative therapeutic solutions that meet the needs of dermatology patients and physicians.

Our experience has taught us that the effects of skin conditions reach much deeper than the skin itself. By treating and caring for skin, we help people improve their quality of life. To achieve this, we pay special attention not only to the efficacy of our products, but also to their cosmetic qualities and galenic properties. This is what makes our products appealing to patients and drives our scientists to explore new areas in dermatological innovation.

Our growing portfolio includes treatment for major skin conditions – acne, rosacea, fungal nail infections, psoriasis, seborrheic dermatitis, non-melanoma skin cancer and photodamage and hyperpigmentation disorders.

Our Mission Statement

Committed to the future of dermatology, Galderma offers innovative therapeutic solutions that improve the quality of life of dermatology patients
.

 

Company Information: Galderma (UK) Limited, company registration number 00715401, Meridien House, 69-71 Clarendon Road, Watford, Herts, WD17 1DS

 

Always read the leaflet.
Curanail Nail Lacquer contains Amorolfine 5% w/v.
Ask your pharmacist for advice.

Galderma United Kingdom - Committed to the Future of Dermatology